Complete Genomics, Inc (GNOM)

[Vertizon]

This was a post from the Yahoo message board from poster dfxoconnor: We already know that they finished the year with somewhere between 3000-3200 sequences. We also know that they were short in the 4th quarter with 600 total. I have their revenue estimated at $3.25M for Q4 which brings their total for 2011 at $20M. This is 2X their earnings for 2010.

I now have their 2012 revenue outlook to double ($40M) based on the known backlog of 6000 sequences (not including Mayo) which I estimate at another 2500. We should get some transparency into the actual Mayo amount in the Q4 conference. This can actually be closer to a 5000 or 10000 sequence contract over time if they prove 95%+ accuracy.

They are also opening revenue channels with business partnership programs; I'm interested to hear more news on this. Hiring and headcount has also been robust, this will be needed to keep up with backlog and the next round of growth.

I anticipate a 20,000 Sequence capacity by 2014 and $100M in revenue.

Outlook is strong. Open your eyes to the next great technology...when this hits the mainstream it will change modern day medicine as we know it. GNOM's biggest problem will be when they have to turn away contracts.


Here is a link to the original post: http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_C/threadview?m=tm&bn=114595&tid=2577&mid=2577&tof=2&frt=2